...held executive positions at Prometheus Laboratories Inc., which was acquired by Nestlé S.A. (SIX:NESN), and Sequus Pharmaceuticals Inc....

...difference in survival rates was statistically significant for Amphotec compared to Abelcet and amphotericin B. Sequus Pharmaceuticals Inc....

...the blood stream undetected by the immune system. SEQU can receive R&D milestones and royalties. Sequus Pharmaceuticals Inc....

...Calif. Business: Neurological Hired: Donald Stewart as CFO; formerly VP of finance and treasurer at Sequus Pharmaceuticals Inc. WIR...

...a cofounder of Sequus Pharmaceuticals Inc. , which developed Doxil doxorubicin, a liposomal cancer drug. In 1999, Sequus...

...Grove as VP of development operations, formerly VP of regulatory affairs at Johnson & Johnson's Sequus Pharmaceuticals Inc....

...cytarabine liposomal Lymphomatous meningitis 4/1/99 SkyePharma 1 (33) Doxil doxorubicin liposomal AIDS-related Kaposi's sarcoma 11/17/95 Sequus...
...now part of Johnson & Johnson) 1 (77) Doxil doxorubicin liposomal Metastatic ovarian carcinoma 6/28/99 Sequus...

...chaired the committee from 1990 to 1992. Henderson later served as chairman and CEO of Sequus Pharmaceuticals Inc....

...general partner of New Enterprise Associates; and John Richard, former EVP of business development at Sequus...

...Cancer accelerated approvals Product Company Indication Date approved Endpoint for accelerated approval Doxil liposomal doxorubicin Sequus...